ESMO Clinical Practice Guideline Express Update on the management of metastatic pancreatic cancer
• This ESMO Clinical Practice Guideline Express Update addresses developments in the management of metastatic pancreatic cancer. • It has been issued following the approval of first-line nanoliposomal irinotecan (NALIRIFOX regimen). • Updated first- and second-line treatment recommendations are provided. • An updated management algorithm for metastatic pancreatic cancer is also included.
Authors
- Thierry Conroy (ORCID: https://orcid.org/0000-0001-7548-284X)
- Michel Ducreux (ORCID: https://orcid.org/0000-0001-8649-7449)
Institutions
- Inserm (FR)
- Université Paris-Saclay (FR)
- Institut Gustave Roussy (FR)
- Institut de Cancérologie de Lorraine (FR)
- Interdisciplinarité en Santé Publique Interventions et Instruments de mesure complexes – Région Est (FR)
Publication Details
- Journal
- ESMO Open
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1016/j.esmoop.2025.104528
- Citations
- 11
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 11.50
Funders
- Kasturba Medical College, Manipal
- European Society for Medical Oncology